# Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer

> **NCT01564810** · PHASE4 · UNKNOWN · sponsor: **Xu jianmin** · enrollment: 150 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Neoplasm Metastasis
- Liver Neoplasms

## Interventions

- **DRUG:** Cetuximab
- **DRUG:** chemotherapy of mFOLFOX6 or FOLFIRI

## Key facts

- **NCT ID:** NCT01564810
- **Lead sponsor:** Xu jianmin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-09
- **Primary completion:** 2012-06
- **Final completion:** 2015-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2012-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01564810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01564810, "Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01564810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*